MPCI Stock Overview
A drug holding company, produces and sells pharmaceutical products for human and veterinary use in Egypt and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Memphis Pharmaceuticals & Chemical Industries Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ج.م61.14 |
| 52 Week High | ج.م139.99 |
| 52 Week Low | ج.م31.00 |
| Beta | 0.20 |
| 11 Month Change | 70.35% |
| 3 Month Change | 75.49% |
| 1 Year Change | 17.74% |
| 33 Year Change | 221.45% |
| 5 Year Change | 534.89% |
| Change since IPO | 102.30% |
Recent News & Updates
Recent updates
Shareholder Returns
| MPCI | EG Pharmaceuticals | EG Market | |
|---|---|---|---|
| 7D | -2.2% | 1.8% | 2.4% |
| 1Y | 17.7% | 41.0% | 32.4% |
Return vs Industry: MPCI underperformed the EG Pharmaceuticals industry which returned 41% over the past year.
Return vs Market: MPCI underperformed the EG Market which returned 32.4% over the past year.
Price Volatility
| MPCI volatility | |
|---|---|
| MPCI Average Weekly Movement | 12.0% |
| Pharmaceuticals Industry Average Movement | 6.4% |
| Market Average Movement | 5.4% |
| 10% most volatile stocks in EG Market | 9.7% |
| 10% least volatile stocks in EG Market | 3.7% |
Stable Share Price: MPCI's share price has been volatile over the past 3 months compared to the EG market.
Volatility Over Time: MPCI's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of EG stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1940 | n/a | Bassem Abdullah | www.memphis.com.eg |
Memphis Pharmaceuticals & Chemical Industries, a drug holding company, produces and sells pharmaceutical products for human and veterinary use in Egypt and internationally. The company offers human health products in various therapeutic areas, including anti-infective, CNS, dermatological, cardio vascular system, corticosteroid, vitamins and minerals, musculo-skeletal system, analgesic and antipyretic, respiratory system, genitourinary system, alimentary tract and metabolism, antihistaminic, antiparasites, and hormones. It also provides animal health products in powder form, as well as in oral and injectable solution forms.
Memphis Pharmaceuticals & Chemical Industries Fundamentals Summary
| MPCI fundamental statistics | |
|---|---|
| Market cap | ج.م343.91m |
| Earnings (TTM) | ج.م191.46m |
| Revenue (TTM) | ج.م871.91m |
1.8x
P/E Ratio0.4x
P/S RatioIs MPCI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MPCI income statement (TTM) | |
|---|---|
| Revenue | ج.م871.91m |
| Cost of Revenue | ج.م573.41m |
| Gross Profit | ج.م298.49m |
| Other Expenses | ج.م107.03m |
| Earnings | ج.م191.46m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 34.04 |
| Gross Margin | 34.23% |
| Net Profit Margin | 21.96% |
| Debt/Equity Ratio | 119.9% |
How did MPCI perform over the long term?
See historical performance and comparisonDividends
6.5%
Current Dividend Yield12%
Payout RatioDoes MPCI pay a reliable dividends?
See MPCI dividend history and benchmarks| Memphis Pharmaceuticals & Chemical Industries dividend dates | |
|---|---|
| Ex Dividend Date | Nov 13 2024 |
| Dividend Pay Date | Nov 17 2024 |
| Days until Ex dividend | 5 days |
| Days until Dividend pay date | 9 days |
Does MPCI pay a reliable dividends?
See MPCI dividend history and benchmarks